Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Clinico-biological features, treatment and survival of 457 patients with histological Grades 3A and 1-2 follicular lymphoma mostly treated with immunochemotherapy.

Literature DB >> 26010479

Clinico-biological features, treatment and survival of 457 patients with histological Grades 3A and 1-2 follicular lymphoma mostly treated with immunochemotherapy.

Santiago Mercadal¹, Helena Pomares², Juan M Sancho³, Fina Climent⁴, Olga García³, Maite Encuentra², Eva Domingo-Doménech², Marc Sorigué³, Miriam Moreno³, Ana C Oliveira², Josep-Maria Ribera³, Alberto Fernández de Sevilla², Eva González-Barca².

Abstract

Entities: Disease Species

Keywords: anthracyclines; follicular lymphoma; histological grades; immunochemotherapy; outcome

Mesh：

Substances：
Anthracyclines
Rituximab

Year: 2015 PMID： 26010479 DOI： 10.1111/bjh.13502

Source DB: PubMed Journal: Br J Haematol ISSN： 0007-1048 Impact factor: 6.998

Keyword Cloud
Cited

× No keyword cloud information.

5 in total

1. A simplified scoring system in de novo follicular lymphoma treated initially with immunochemotherapy.

Authors: Emmanuel Bachy; Matthew J Maurer; Thomas M Habermann; Bénédicte Gelas-Dore; Delphine Maucort-Boulch; Jane A Estell; Eric Van den Neste; Réda Bouabdallah; Emmanuel Gyan; Andrew L Feldman; Joan Bargay; Alain Delmer; Susan L Slager; Maria Gomes da Silva; Olivier Fitoussi; David Belada; Hervé Maisonneuve; Tanin Intragumtornchai; Stephen M Ansell; Thierry Lamy; Peggy Dartigues; Brian K Link; John F Seymour; James R Cerhan; Gilles Salles
Journal: Blood Date: 2018-04-17 Impact factor: 22.113

Clinico-biological features, treatment and survival of 457 patients with histological Grades 3A and 1-2 follicular lymphoma mostly treated with immunochemotherapy.

1. A simplified scoring system in de novo follicular lymphoma treated initially with immunochemotherapy.

Review 2. Systemic Front Line Therapy of Follicular Lymphoma: When, to Whom and How.

Review 3. Novel treatment approaches and future perspectives in follicular lymphoma.

4. Prediction of prognosis and pathologic grade in follicular lymphoma using ¹⁸F-FDG PET/CT.

5. [Clinical characteristics and survival analysis of de novo grade 3 or transformed follicular lymphoma patients].

Clinico-biological features, treatment and survival of 457 patients with histological Grades 3A and 1-2 follicular lymphoma mostly treated with immunochemotherapy.

1. A simplified scoring system in de novo follicular lymphoma treated initially with immunochemotherapy.

Review 2. Systemic Front Line Therapy of Follicular Lymphoma: When, to Whom and How.

Review 3. Novel treatment approaches and future perspectives in follicular lymphoma.

4. Prediction of prognosis and pathologic grade in follicular lymphoma using 18F-FDG PET/CT.

5. [Clinical characteristics and survival analysis of de novo grade 3 or transformed follicular lymphoma patients].

4. Prediction of prognosis and pathologic grade in follicular lymphoma using ¹⁸F-FDG PET/CT.